Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) EPS (Basic): 2010-2025

Historic EPS (Basic) for Niagen Bioscience (NAGE) over the last 14 years, with Sep 2025 value amounting to $0.06.

  • Niagen Bioscience's EPS (Basic) rose 200.00% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.27, marking a year-over-year increase of 2285.39%. This contributed to the annual value of $0.11 for FY2024, which is 257.14% up from last year.
  • According to the latest figures from Q3 2025, Niagen Bioscience's EPS (Basic) is $0.06, which was up 20.00% from $0.05 recorded in Q2 2025.
  • Niagen Bioscience's 5-year EPS (Basic) high stood at $0.09 for Q4 2024, and its period low was -$0.13 during Q3 2021.
  • Over the past 3 years, Niagen Bioscience's median EPS (Basic) value was $0.00 (recorded in 2023), while the average stood at $0.02.
  • Per our database at Business Quant, Niagen Bioscience's EPS (Basic) crashed by 85.71% in 2021 and then skyrocketed by 25,279.60% in 2025.
  • Over the past 5 years, Niagen Bioscience's EPS (Basic) (Quarterly) stood at -$0.07 in 2021, then soared by 71.43% to -$0.02 in 2022, then skyrocketed by 107.59% to $0.00 in 2023, then spiked by 5,830.88% to $0.09 in 2024, then spiked by 200.00% to $0.06 in 2025.
  • Its last three reported values are $0.06 in Q3 2025, $0.05 for Q2 2025, and $0.07 during Q1 2025.